Area of research
Cardiology and Cardiovascular Medicine · Molecular Biology
Research interest
Research focused on Phospholamban and Induced pluripotent stem cell, with related work in Transcription activator-like effector nuclease, Sotalol, Ejection fraction. Notable publications include 'Correction of human phospholamban R14del mutation associated with cardiomyopathy using targeted nucleases and combination therapy', 'Modeling susceptibility to drug-induced long QT with a panel of subject-specific induced pluripotent stem cells', and 'Gene editing reverses arrhythmia susceptibility in humanized PLN-R14del mice: modelling a European cardiomyopathy with global impact'.